IP Library Granted Patent US 10,428,019
Granted Patent B2
US 10,428,019 · App. 13/825,627 · Granted Oct 1, 2019

Chiral auxiliaries

Inventors: Takeshi Wada (Chiba, JP); Mamoru Shimizu (Okinawa, JP)
Assignee: WAVE LIFE SCIENCES LTD.
C07D207/12C07D207/16C07D209/62C07D211/42C07D211/44C07D211/62C07D217/24C07D221/10C07D221/18C07H1/00C07H19/06C07H19/16C07H21/00C07H21/02C07H21/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,428,019
App. No.
13/825,627
Granted
Oct 1, 2019
Kind
B2
Abstract

The disclosed and claimed compounds are chiral auxiliaries useful for efficiently producing a phosphorus atom-modified nucleic acid derivative with high stereoregularity. The disclosed and claimed compounds include those represented by the following formula (I) or formula (XI) for introducing the chiral auxiliaries.

Claims (43)

1. A nucleic acid derivative comprising a chiral auxiliary, wherein the chiral auxiliary is represented by formula (II) and binds to a phosphorus atom of a phosphite moiety of the nucleic acid derivative through the oxygen atom of the chiral auxiliary, wherein the squiggly line represents the point of attachment to a phosphorus atom of a phosphite moiety of the nucleic acid derivative:

in which R 1 and R 2 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group;

R 3 represents an unsubstituted or substituted aryl group or an unsubstituted or substituted alkyl group;

R 4 and R 5 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group;

Y represents -Y 1 -Y 2 -, where Y 1 represents —C(R 6 )(R 7 )— in which R 6 and R 7 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group, or Y 1 represents an unsubstituted or substituted o-aryldiyl group, and Y 2 represents a single bond or —C(R 8 )(R 9 )— in which R 8 and R 9 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group.

2. The nucleic acid derivative of claim 1 , wherein R 3 represents an unsubstituted or substituted aryl group.

3. The nucleic acid derivative of claim 2 , wherein Y 2 represents a single bond.

4. The nucleic acid derivative of claim 1 , wherein Y 1 represents an unsubstituted or substituted o-aryldiyl group.

5. A nucleoside-3′-phosphoramidite reagent represented by formula (IV):

in which R 1 and R 2 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group;

R 3 represents an unsubstituted or substituted aryl group or an unsubstituted or substituted alkyl group;

R 4 and R 5 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group;

Y represents -Y 1 -Y 2 -, where Y 1 represents —C(R 6 )(R 7 )— in which R 6 and R 7 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group, or Y 1 represents an unsubstituted or substituted o-aryldiyl group, and Y 2 represents a single bond or —C(R 8 )(R 9 )— in which R 8 and R 9 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group;

R 21 represents a protective group of a hydroxyl group;

R 22 represents a hydrogen atom, an alkoxy group, a fluorine atom, or a protected hydroxyl group; and

Bs represents a nucleobase.

6. The reagent of claim 5 , wherein R 3 represents an unsubstituted or substituted aryl group.

7. The reagent of claim 5 , wherein Y 1 represents an unsubstituted or substituted o-aryldiyl group.

8. The reagent of claim 7 , wherein Y 2 represents a single bond.

9. A compound represented by formula (XI), or a salt thereof:

in which R 101 and R 102 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group;

R 103 represents a cyano group, a halogen atom, a halogenated unsubstituted or substituted alkyl group, a substituted or unsubstituted halogenated alkanoyl group, a C 1 -C 6 alkylsulfonyl group, a substituted or unsubstituted halogenated alkylsulfonyl group, or a nitro group;

Z represents -Z 1 -Z 2 -, in which Z 1 represents —C(R 104 )(R 105 )— wherein R 104 and R 105 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group, and Z 2 represents a single bond or —C(R 106 )(R 107 )— wherein R 106 and R 107 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group.

10. The compound or a salt thereof according to claim 9 , wherein R 101 and R 102 are independently a hydrogen atom or an unsubstituted or substituted alkyl group, R 103 is a cyano group, and Z is —C(R 104 )(R 105 )— wherein R 104 and R 105 are independently a hydrogen atom or an unsubstituted or substituted alkyl group.

11. The compound or a salt thereof of claim 9 , wherein R 101 and R 102 are hydrogen atoms, R 103 is a cyano group, and Z is —C(R 106 )(R 105 )— wherein R 104 and R 105 are hydrogen atoms.

12. The compound or a salt thereof of claim 9 , wherein R 103 is a cyano group.

13. A nucleic acid derivative, wherein a chiral auxiliary represented by the following general formula (XII) binds to a phosphorus atom of a phosphite moiety of the nucleic acid derivative through the oxygen of the chiral auxiliary, wherein the squiggly line represents the point of attachment to a phosphorus atom of a phosphite moiety of the nucleic acid derivative:

in which R 101 and R 102 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group;

R 103 represents a cyano group, a halogen atom, a halogenated unsubstituted or substituted alkyl group, a substituted or unsubstituted halogenated alkanoyl group, a C 1 -C 6 alkylsulfonyl group, a substituted or unsubstituted halogenated alkylsulfonyl group, or a nitro group; and

Z represents -Z 1 -Z 2 -, in which Z 1 represents —C(R 104 )(R 105 )— wherein R 104 and R 105 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group, and Z 2 represents a single bond or —C(R 106 )(R 107 )— wherein R 106 and R 107 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group.

14. The nucleic acid derivative of claim 13 , wherein R 103 is a cyano group.

15. The nucleic acid derivative of claim 14 , wherein R 101 and R 102 are independently a hydrogen atom or an unsubstituted or substituted alkyl group, and Z is —C(R 104 )(R 105 )— wherein R 104 and R 105 are independently a hydrogen atom or an unsubstituted or substituted alkyl group.

16. The nucleic acid derivative of claim 14 , wherein R 101 and R 102 are hydrogen atoms, and Z is —C(R 104 )(R 105 )— wherein R 104 and R 105 are hydrogen atoms.

17. A nucleoside-3′-phosphoramidite reagent represented by formula (XIV):

in which R 101 and R 102 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group;

R 103 represents a cyano group, a halogen atom, a halogenated unsubstituted or substituted alkyl group, a substituted or unsubstituted halogenated alkanoyl group, a C 1 -C 6 alkylsulfonyl group, a substituted or unsubstituted halogenated alkylsulfonyl group, or a nitro group;

Z represents -Z 1 -Z 2 -, in which Z 1 represents —C(R 104 )(R 105 )— wherein R 104 and R 105 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group, and Z 2 represents a single bond or —C(R 106 )(R 107 )— wherein R 106 and R 107 independently represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, an unsubstituted or substituted alkynyl group, an unsubstituted or substituted alkoxy group, an unsubstituted or substituted aralkyl group, or an unsubstituted or substituted aryl group;

R 121 represents a protective group of a hydroxyl group;

R 122 represents a hydrogen atom, an alkoxy group, a fluorine atom, or a protected hydroxyl group; and

Bs represents a nucleobase.

18. The nucleoside of claim 17 , wherein R 103 is a cyano group.

19. The nucleoside of claim 18 , wherein R 101 and R 102 are independently a hydrogen atom or an unsubstituted or substituted alkyl group, and Z is —C(R 104 )(R 105 )— wherein R 104 and R 105 are independently a hydrogen atom or an unsubstituted or substituted alkyl group.

20. The nucleoside of claim 18 , wherein R 101 and R 102 are hydrogen atoms, and Z is —C(R 104 )(R 105 )— wherein R 104 and R 105 are hydrogen atoms.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2017
From: WAVE LIFE SCIENCES JAPAN, INC.
To: WAVE LIFE SCIENCES LTD.
Reel/Frame 044346/0972 →
CHANGE OF NAME Recorded Jun 13, 2016
From: WAVE LIFE SCIENCES JAPAN
To: WAVE LIFE SCIENCES JAPAN, INC.
Reel/Frame 038978/0843 →
CHANGE OF NAME Recorded Aug 3, 2015
From: CHIRALGEN, LTD.
To: WAVE LIFE SCIENCES JAPAN
Reel/Frame 036236/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2013
From: WADA, TAKESHI; SHIMIZU, MAMORU
To: CHIRALGEN, LTD.
Reel/Frame 030069/0946 →
Continuity (2)
Provisional Application 61386016 · Sep 24, 2010
Related Publication 20130178612A1 · Jul 11, 2013
Cited By (10)
US 12,391,942 US 12,403,156 US 12,428,442 US 12,435,105 US 12,473,321 US 12,486,505 US 12,552,743 US 12,590,115 US 12,637,672 US 12,674,168